Max Robotics — Global Service Robot Directory + US Certification

About

Gilles Delahaut is a pioneering head and neck surgeon whose work centers on advancing minimally invasive, organ-sparing techniques for laryngeal and hypopharyngeal cancers. His major contributions lie in the development and refinement of transoral robotic surgery (TORS), particularly for total laryngectomy and hypopharyngectomy. His 2018 paper, "Transoral Robotic Surgery Total Laryngectomy" (28 citations), provides a comprehensive operative technique using the da Vinci system, establishing a novel, less morbid alternative to traditional open surgery. This work is complemented by his 2020 study on TORS hypopharyngectomy (16 citations), demonstrating the feasibility and outcomes of this approach. More recently, Delahaut is leading the SUPRA-QoL trial (2023, 7 citations), an ambitious prospective evaluation that compares oncological outcomes, functional recovery, quality of life, and cost-effectiveness of advanced technologies for supraglottic cancer. By systematically replacing total laryngectomy with function-sparing techniques, his research directly improves patient survival and quality of life. With a growing citation impact, Delahaut is a key figure in the robotic revolution of head and neck oncology, bridging surgical innovation with rigorous clinical evidence.